Sort
25,944 grants matching “neurodegeneration”
Limbic System Function in Carriers of the Fragile X Premutation
$677,700David R Hessl · University Of California At Davis · R01 · FY2011 · MH
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$677,625Matthew D Disney · University Of Florida · P01 · FY2021 · NS
Atomic models of human tau filaments and development of tau ligands
$677,271Ruben Vidal · Indiana University Indianapolis · U01 · FY2022 · NS
Enhancement of Brain Dysfunction in Sepsis Survivors by Alzheimerâs Disease Neuropathology
$677,257Benjamin Herschel Singer · University Of Michigan At Ann Arbor · R01 · FY2023 · AG
Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
$677,137Peter Alexander Ljubenkov · University Of California, San Francisco · R01 · FY2021 · AG
Targeting neuroinflammation in AD with novel CX3CR1 agonists
$677,072Layton Harris Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
$676,854Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2013 · MH
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology
$676,835Barry Setlow · University Of Florida · R01 · FY2023 · AG
Gene expression in the human brain
$676,680Mark Cookson · National Institute On Aging · ZIA · FY2021 · AG
Precision Medicine for Inherited Retinal Degenerations
$676,658Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2022 · EY
Alternative vacuolar targeting mechanisms in yeast
$676,508Daniel J. Klionsky · University Of Michigan At Ann Arbor · R01 · FY2008 · GM
Dendrite development, function, degeneration and regeneration
$676,090Yuh Nung Jan · University Of California, San Francisco · R35 · FY2025 · NS
Core B-Clinical Core
$676,054David Sultzer · University Of California-Irvine · P30 · FY2022 · AG
Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers
$676,016Andrew J Saykin · Indiana University Indianapolis · R01 · FY2019 · AG
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's Disease
$675,983Brea Louise Perry · Trustees Of Indiana University · R01 · FY2022 · AG
Neuroimaging Core
$675,916John A Detre · University Of Pennsylvania · P30 · FY2023 · AG
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve Regeneration
$675,385Yang Hu · Stanford University · R01 · FY2025 · EY
Bidirectional interactions between sleep and Alzheimer's disease: Functional dissection of the brain transcriptome in humans and Drosophila
$675,211Paul J Shaw · Washington University · R01 · FY2025 · AG
Identification of novel four repeat tauopathies through analysis of network vulnerability, tau structure and propagation.
$675,204Ruben Vidal · Indiana University Indianapolis · R01 · FY2024 · AG
Role of mitochondrial GDAP1 in Alzheimer's disease
$675,067Kirill Kiselyov · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Role of mitochondrial GDAP1 in Alzheimer's disease
$675,067Kirill Kiselyov · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers
$675,065David R Hessl · University Of California At Davis · R01 · FY2013 · MH
Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis
$674,948Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Utilization of proteomics and lipidomics to identify modifiers of LBD
$674,800Junmin Peng · Mayo Clinic Jacksonville · U54 · FY2020 · NS
Utilization of proteomics and lipidomics to identify modifiers of LBD
$674,800Junmin Peng · Mayo Clinic Jacksonville · U54 · FY2021 · NS